CBDMD INC (YCBD) Stock Price, Quote, News and Overview
NYSEARCA:YCBD - NYSE Arca - US12482W3097 - Common Stock - Currency: USD
YCBD Quote, Performance and Key Statistics
0.966
+0.04 (+4.32%)
The current stock price of YCBD is 0.966 USD. In the past month the price increased by 15.27%. In the past year, price decreased by -79.88%.
YCBD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 56.08 | 731.38B | ||
| JNJ | JOHNSON & JOHNSON | 16.37 | 393.87B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 17.62 | 285.75B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.04 | 225.65B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 15.81 | 213.28B | ||
| MRK | MERCK & CO. INC. | 10.26 | 200.78B | ||
| PFE | PFIZER INC | 7.62 | 139.12B | ||
| SNY | SANOFI-ADR | 10.71 | 117.66B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.45 | 96.38B | ||
| GSK | GSK PLC-SPON ADR | 8.21 | 73.46B | ||
| ZTS | ZOETIS INC | 24.68 | 66.16B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 62.74 | 45.07B |
Related stock screener links
About YCBD
Company Profile
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Company Info
CBDMD INC
8845 Red Oak Blvd
Charlotte NORTH CAROLINA 28217 US
CEO: Martin A. Sumichrast
Employees: 42
Phone: 17044453060
CBDMD INC / YCBD FAQ
What is the stock price of CBDMD INC today?
The current stock price of YCBD is 0.966 USD. The price increased by 4.32% in the last trading session.
What is the ticker symbol for CBDMD INC stock?
The exchange symbol of CBDMD INC is YCBD and it is listed on the NYSE Arca exchange.
On which exchange is YCBD stock listed?
YCBD stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CBDMD INC stock?
7 analysts have analysed YCBD and the average price target is 3.06 USD. This implies a price increase of 216.77% is expected in the next year compared to the current price of 0.966. Check the CBDMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CBDMD INC worth?
CBDMD INC (YCBD) has a market capitalization of 8.61M USD. This makes YCBD a Nano Cap stock.
How many employees does CBDMD INC have?
CBDMD INC (YCBD) currently has 42 employees.
What are the support and resistance levels for CBDMD INC (YCBD) stock?
CBDMD INC (YCBD) has a support level at 0.9 and a resistance level at 0.98. Check the full technical report for a detailed analysis of YCBD support and resistance levels.
Is CBDMD INC (YCBD) expected to grow?
The Revenue of CBDMD INC (YCBD) is expected to grow by 9.38% in the next year. Check the estimates tab for more information on the YCBD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CBDMD INC (YCBD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of YCBD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of YCBD, evaluating the profitability, health, valuation and growth aspects
- CBDMD INC (YCBD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CBDMD INC (YCBD) Sales and EPS estimates to see what analysts future expectations are.
- CBDMD INC (YCBD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CBDMD INC (YCBD) Insider and Institutional Ownership to learn about the owners and their transactions.
- CBDMD INC (YCBD) Stock Chart to make your own analysis
- CBDMD INC (YCBD) Latest news and press-releases to stay up to date.
Does CBDMD INC (YCBD) stock pay dividends?
YCBD does not pay a dividend.
When does CBDMD INC (YCBD) report earnings?
CBDMD INC (YCBD) will report earnings on 2025-08-12.
What is the Price/Earnings (PE) ratio of CBDMD INC (YCBD)?
CBDMD INC (YCBD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.18).
What is the Short Interest ratio of CBDMD INC (YCBD) stock?
The outstanding short interest for CBDMD INC (YCBD) is 0.87% of its float. Check the ownership tab for more information on the YCBD short interest.
YCBD Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to YCBD. When comparing the yearly performance of all stocks, YCBD is a bad performer in the overall market: 98.64% of all stocks are doing better.
YCBD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to YCBD. YCBD has a bad profitability rating. Also its financial health evaluation is rather negative.
YCBD Financial Highlights
Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -5.18. The EPS increased by 96.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.06% | ||
| ROE | -625.23% | ||
| Debt/Equity | 0 |
YCBD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to YCBD. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 71.11% and a revenue growth 9.38% for YCBD